GL1X · GenesisL1 explorer

MolNFT v1 · #64561 · protein

Design and preparation of potent, non-peptidic, bioavailable renin inhibitors

3G70: “Design and preparation of potent, non-peptidic, bioavailable renin inhibitors”. X-ray diffraction, 2 ligands (A5T, NAG), 3 pockets (best druggability 0.75). MolNFT v1 #64561 on GenesisL1: 3D structure, binding sites and pockets in…

PDB
3G70
Type
protein
Length
671 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Renin
EC
3.4.23.15
UniProt
P00797
Ligands
A5T, NAG
Pockets
3 · best druggability 0.75

Structure

x-ray diffraction · 2 distinct chains · 15% helix, 45% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ARenin (EC 3.4.23.15)protein33416% helix, 46% strandP00797
BRenin (EC 3.4.23.15)protein33715% helix, 45% strandP00797

Ligands and binding sites

  • A5T · (1R,5S)-7-{4-[3-(2-chloro-3,6-difluorophenoxy)propyl]phenyl}-N-cyclopropyl-N-(2,3-dichlorobenzyl)-3,9-diazabicyclo[3.3.1]non-6-ene-6-carboxamide · ligand · 2 copies · chains A, B
  • NAG · 2-acetamido-2-deoxy-beta-D-glucopyranose · sugar · 2 copies · chains A, B
  • DMS · Dimethyl sulfoxide · additive · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
17980.750.7967A5T, DMS
27500.750.7952A5T, DMS
3650.420.8118empty

Modifications

Observed in the structure: 5 disulfide, 2 glycan (disulfide, N-glycosylation).

Compared structures

  • 3G70 · Design and Preparation of Potent, Non-Peptidic, Bioavailable Renin Inhibitors · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.